Retrospective analysis evaluates dose coverage in craniospinal irradiation, indicating optimal overlap lengths for treatment effectiveness.
BACKGROUND/AIM: Patients with meningeosis carcinomatosa or primary brain tumors may require craniospinal irradiation. In craniospinal volumetric modulated arc therapy (VMAT-CSI), field junctions are sensitive regions prone to underdosage. This study investigated whether global, planning target volume (PTV)-based quality metrics can detect such localized deficits and how different field-overlap widths affect junction dosimetry. PATIENTS AND METHODS: Retrospective computed tomography datasets from six patients were analyzed. For each patient, VMAT-CSI plans with overlap lengths of 4, 6, 8, 10, and 12 cm were generated. Dose coverage (D98%) and homogeneity index (HI) were evaluated for the PTV and a junction-focused subvolume (PTV-VOI). Conformity indices (RTOG, Salt-Lomax, Lomax, and Van't Riet) were calculated for both structures. RESULTS: Increasing overlap improved D98% for both PTV and PTV-VOI. While the PTV often met D98% ≥95% at small overlaps, adequate PTV-VOI coverage was achieved only at ≥10 cm. VOI-based RTOG and Salt-Lomax indices increased with overlap, the Lomax index decreased slightly, and Van't Riet remained stable. Global PTV-based indices showed minimal variation. CONCLUSION: Adequate dose coverage at the field junctions in VMAT-CSI treatment is achieved with field overlaps of 10-12 cm. Since global PTV metrics mask local underdosages, clinicians should use VOI assessments at the field junctions rather than relying solely on global plan indices.
No takes yet. Share an insight, caveat, or question.
Ziemann et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: